Adeline Gillet

FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3.

P. Ruszniewski, A. Couvelard, V. Rebours, 2012, Endocrine-related cancer.